Foxo4-DRI 5mg

170 $

Foxo4-DRI 5mg is a research-grade peptide supplied at ≥99% purity for laboratory research use only. Alluvia provides a Certificate of Analysis with every batch. Not for human consumption.

For Research Use OnlyThis product is supplied strictly for laboratory and in-vitro research by qualified researchers. It is not for human or animal consumption and is not a drug, food, cosmetic or dietary supplement.
Download Certificate of Analysis (PDF)

100 in stock

Description

Foxo4-DRI 5mg — Research-Grade Peptide (≥99% Purity)

Foxo4-DRI is a senolytic peptide targeting worn-out cells. It is supplied by
Alluvia as a high-purity reference peptide for laboratory
and research applications, and is studied in research relating to senescent-cell clearance.

Mechanism of Action in Research

In published and preclinical research, Foxo4-DRI disrupts the FOXO4–p53 interaction to help clear the senescent ‘zombie’ cells linked to ageing.
Alluvia supplies every batch at ≥99% purity, verified by independent HPLC
and mass-spectrometry testing so researchers know exactly what they are working
with.

Areas of Research Interest

Foxo4-DRI has been investigated by researchers in connection with:

  • Targets senescent cells
  • Supports healthy-ageing research goals
  • A cutting-edge senolytic
  • Used in advanced longevity protocols

Research-Grade Quality from Alluvia (Australia)

  • ≥99% purity — independently lab-tested with a downloadable Certificate of Analysis
  • Australian-based dispatch with fast, tracked shipping
  • Cold-chain handling and stable storage for full potency on arrival
  • Responsive local support and secure checkout

Important — Research Use Only

Foxo4-DRI is sold for laboratory and research use only. It
is intended exclusively for in-vitro experimentation and scientific study by
qualified researchers. It is not for human or animal consumption
and is not a drug, food, cosmetic or dietary supplement. By purchasing, you
confirm you are a qualified researcher or institution and accept full
responsibility for safe, lawful handling and disposal.

Frequently Asked Questions

What is Foxo4-DRI?

Foxo4-DRI is a senolytic peptide targeting worn-out cells. In the laboratory it is studied in research relating to senescent-cell clearance. In research models, Foxo4-DRI disrupts the FOXO4–p53 interaction to help clear the senescent ‘zombie’ cells linked to ageing.

Is Foxo4-DRI for human use?

No. Foxo4-DRI is supplied strictly as a research chemical for in-vitro and laboratory study. It is not a medicine, supplement, cosmetic or food, and is not for human or animal consumption.

How should Foxo4-DRI be stored and handled?

Store lyophilised Foxo4-DRI frozen and away from light. After reconstitution with bacteriostatic water, keep refrigerated at 2–8°C and handle using appropriate laboratory safety practices.

Does Foxo4-DRI ship within Australia?

Yes. Alluvia dispatches Foxo4-DRI 5mg Australia-wide, with a Certificate of Analysis confirming ≥99% purity for every batch.

Additional information

Purity

≥99%

Certificate of Analysis

RP-HPLC purity: 99.5%

Every batch is released against Alluvia Peptides specifications with identity (ESI-MS), RP-HPLC purity, water and acetate content verified. This material is supplied for laboratory research use only.

Certificate of Analysis preview

Download COA (PDF)

Reviews

There are no reviews yet.

Be the first to review “Foxo4-DRI 5mg”

Your email address will not be published. Required fields are marked *